March 28, 2008 (Milan) — Despite increased perioperative complications, laparoscopic cryotherapy for larger (>3 cm) renal tumors is safe and feasible, with no increased risk for bleeding, according to ...
CAESAREA, Israel, Dec. 5, 2024 /PRNewswire/ -- IceCure Medical Ltd. (ICCM) (NASDAQ: ICCM) ('IceCure', 'IceCure Medical' or the 'Company'), developer of minimally-invasive cryoablation technology that ...
Percutaneous cryoablation of larger renal masses can be performed with high technical success and low complication rates, according to researchers. Grant D. Schmit, MD, and colleagues at Mayo Clinic ...
Laparoscopic and percutaneous approaches have similar short-term efficacy in treating renal tumors. Laparoscopic (LAP) and CT-guided percutaneous (PERC) cryoablation for renal tumors result in similar ...
Interim Data confirm ProSense® cryoablation is highly effective for kidney tumors ≤3 cm and a safe procedure for kidney tumors ≤5 cm in people ineligible for surgery CAESAREA, Israel, March 24, 2025 ...
For patients with primary localized renal cell carcinoma (RCC), especially those who aren’t good candidates for surgery, noninvasive or minimally invasive ablative treatments have emerged as important ...
IceCure Medical’s ProSense® Cryoablation technology shows promise in treating kidney tumors with an 88.7% recurrence-free rate in patients unable to undergo surgery, based on interim results from the ...
The Gauteng MEC for Health & Wellness, Nomantu Nkomo-Ralehoko, announced on X (Twitter) that the Steve Biko Academic Hospital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results